| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bifidobacterium adolescentis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bifidobacterium breve co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bifidobacterium longum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bifidobacterium ruminatum co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bifidobacterium ruminatum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Collinsella intestinalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Collinsella intestinalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Eggerthella lenta co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Bacteroidetes |
| Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Alistipes indistinctus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides coprophilus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides dorei co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides dorei co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides eggerthii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides fragilis co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides fragilis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides fragilis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides fragilis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides intestinalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides ovatus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides sartorii co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides sartorii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides sartorii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides sartorii co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides stercoris co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides thetaiotaomicron co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides thetaiotaomicron co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides thetaiotaomicron co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides uniformis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides vulgatus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides vulgatus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides vulgatus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides xylanisolvens co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides xylanisolvens co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides xylanisolvens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides xylanisolvens co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Odoribacter splanchnicus co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Odoribacter splanchnicus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Odoribacter splanchnicus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Odoribacter splanchnicus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Parabacteroides distasonis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Parabacteroides distasonis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Parabacteroides distasonis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Parabacteroides johnsonii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Parabacteroides johnsonii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Parabacteroides merdae co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Parabacteroides merdae co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Prevotella copri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Firmicutes |
| Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Anaerobutyricum hallii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Anaerococcus hydrogenalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Anaerostipes hadrus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Anaerostipes hadrus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides pectinophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Bacteroides pectinophilus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Etodolac |
Click to Show/Hide the Detail |
| Drug ID |
DR0666
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Blautia hansenii co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Blautia hansenii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Blautia luti (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Blautia luti co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Clostridioides difficile co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Clostridium botulinum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium scindens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Clostridium scindens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium spiroforme (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Clostridium spiroforme co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Coprococcus comes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Coprococcus comes co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Dorea formicigenerans co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Enterocloster asparagiformis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Enterocloster bolteae co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Enterococcus faecalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Erysipelatoclostridium ramosum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Eubacterium rectale (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Eubacterium rectale co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Holdemanella biformis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Hungatella hathewayi co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lactobacillus gasseri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Bazedoxifene |
Click to Show/Hide the Detail |
| Drug ID |
DR0177
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Lactobacillus gasseri co-metabolize the drug Bazedoxifene, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [6] |
| Lactobacillus reuteri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Lactobacillus reuteri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Marvinbryantia formatexigens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Marvinbryantia formatexigens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Roseburia intestinalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Ruminococcus torques (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Ruminococcus torques co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Subdoligranulum variabile co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Lentisphaerae |
| Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Victivallis vadensis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Proteobacteria |
| Edwardsiella tarda (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Edwardsiella tarda co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Enterobacter cancerogenus (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Enterobacter cancerogenus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Escherichia coli co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Proteus penneri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Proteus penneri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Providencia alcalifaciens (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Providencia alcalifaciens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Providencia rettgeri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Providencia rettgeri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Providencia stuartii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Providencia stuartii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Salmonella enterica co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Verrucomicrobia |
| Akkermansia muciniphila (verrucomicrobiae) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A10 (UGT1A10) and Akkermansia muciniphila co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
|
|
|
|
|
|